Results 51 to 60 of about 23,004 (191)

Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments

Pharmaceuticals, 2020
The pharmacological treatment of cognitive impairments associated with schizophrenia is still a major unmet clinical need. Indeed, treatments with available antipsychotics generate highly variable cognitive responses among patients with schizophrenia ...
Sebastiano Alfio Torrisi, Samuele Laudani, Gabriella Contarini, Angelina De Luca, Federica Geraci, Francesca Managò, Francesco Papaleo, Salvatore Salomone, Filippo Drago, Gian Marco Leggio   +9 more
doaj   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

The impact of atypical antipsychotics on the development of type 2 diabetes mellitus

Клинический разбор в общей медицине
Atypical antipsychotics (novell atypical generation antipsychotics) have entered clinical practice recently, but despite this, they have already managed to occupy one of the leading positions in modern therapy of mental disorders such as schizophrenia ...
Sabina E. Kurtmambetova, Yana V. Andrukh, Ruslan E. Kurtmambetov, Elena N. Primysheva, Irina N. Repinskaya   +4 more
doaj   +1 more source

The Effects of Serotonin-Dopamin Antagonistic Atypical Antipsychotics Currently Used in Turkey on Cognitive Dysfunctions in Schizophrenia: A Brief Review [PDF]

Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2004
There are considerable differences in the assessment of schizophrenic symptoms in the last 20 years. Formerly, the focus of assessments was observable symptoms like hallucinations and paranoid symptoms but recently neurodevelopmental and cognitive ...
Bülent Kayahan, Baybars Veznedaroğlu
doaj  

Severe tardive dystonia on low dose short duration exposure to atypical antipsychotics: Factors explored

Indian Journal of Psychological Medicine, 2017
Tardive dystonia (TD) is a serious side effect of antipsychotic medications, more with typical antipsychotics, that is potentially irreversible in affected patients. Studies show that newer atypical antipsychotics have a lower risk of TD.
Nilanjan C Chandra, Shabina A Sheth, Ritambhara Y Mehta, Kamlesh R Dave   +3 more
doaj   +1 more source

Functional and structural connectivity of thalamic subnuclei in major depressive disorder at 7 Tesla

Psychiatry and Clinical Neurosciences, EarlyView.
Aims Major depressive disorder (MDD) is widely considered to be a mood disorder characterized by altered connectivity. The thalamus plays an important role in MDD by connecting large areas of the brain. Here, we explored thalamic connectivity in MDD at the subnuclear level using ultra‐high‐field MRI.
Weijian Liu, Shu Liu, Jurjen Heij, Laurens A. van de Mortel, Luka Liebrand, Matthan Caan, Wietske van der Zwaag, Dick J. Veltman, Lin Lu, Moji Aghajani, Guido van Wingen   +10 more
wiley   +1 more source

The Effects of Atypical Antipsychotic Usage Duration on Serum Adiponectin Levels and Other Metabolic Parameters

Eurasian Journal of Medicine, 2011
Objective: Although atypical antipsychotics are well-tolerated and effective treatment options for schizophrenia, they have metabolic side effects, including weight gain and increased risk of Type II Diabetes Mellitus (DM).
Elif Oral, Mustafa Gulec, Nezahat Kurt, Sumeyra Yilmaz, Nazan Aydin, Ismet Kirpinar   +5 more
doaj  

Psychobiotics and the microbiota–gut–brain axis: Emerging paradigms in mental health modulation

Experimental Physiology, EarlyView.
Abstract The global rise in mental health conditions has prompted interest in interventions that act beyond conventional psychopharmacology. Psychobiotics, broadly understood as live microorganisms or microbe‐derived products that interact with the microbiota–gut–brain axis, have been suggested to exert neuroactive effects through neural, immune ...
Amir Arsalan Ghahari, Mehrdad Nourizadeh, Mehrdad SalekShahabi, Shaghayegh Davari, Saeid Mohammadzadeh Mounesyar   +4 more
wiley   +1 more source

Dietary Quality in Bipolar Disorder Compared to Unipolar Depression (Current and Remitted) and Healthy Controls: The Netherlands Study of Depression and Anxiety

Bipolar Disorders, Volume 28, Issue 3, May 2026.
ABSTRACT Background Patients with bipolar disorder (BD) have an increased risk to develop cardiovascular disease. Western diets have been hypothesized to increase the risk of cardiovascular disease in BD, but dietary habits in BD have not been extensively studied.
M. A. Riedinger, M. Koenders, H. W. Jeuring, M. L. Molendijk, B. W. J. H. Penninx, N. J. A. van der Wee, M. de Leeuw, E. J. Giltay   +7 more
wiley   +1 more source

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

Pharmaceuticals, 2010
Antidepressant therapies, such as selective serotonin reuptake inhibitors (SSRIs), are current first-line treatments for Major Depressive Disorder. However, over 50% of treated patients show an inadequate response to initial antidepressant therapy.
Allan H. Young, Holly MacPherson, Rubo J. Seo   +2 more
doaj   +1 more source